Name

Myralis

Legal name

Myralis

Website

https://myralis.com.br

Company type

Private

Operating status

Operating

Headcount range

501–1,000 employees

Ownership category

akta.pro rank

Product category

Consumer Health Products

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421), Drugs and Druggists' Sundries Merchant Wholesalers (4242)

SIC

Medicinal Chemicals & Botanical Products (2833), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Specialty Condition Supplements (Sleep, Stress, Heart, Joint, Gut, Immunity) (CRADAGAE)

akta.pro secondary industries

Multivitamins & Daily Packs (CRADAGAC), Herbal & Botanical Supplements (CRADAGAD)

Keywords

• Dietary supplements
• Consumer health products
• OTC medications
• Vitamin supplements
• Pharmaceutical manufacturing

Headquarters

HQ city

São Paulo

HQ country

Brazil

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D

Revenue model

1. Pharmaceutical and Health Supplements Sales: Myralis generates revenue through the sale of over-the-counter pharmaceutical products, dietary supplements, and medical devices. Products are distributed through pharmacies, drugstores, and online retail channels across Brazil. The company produces over 50 million products annually across more than 30 brands.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Myralis manufactures and supplies a portfolio of more than 30 health-focused brands including food supplements (vitamin D, B12, cranberry extract), pediatric supplements, OTC medications (osmotic laxatives), and medical devices (nasal wash). Products are distributed through major pharmacy chains, independent drugstores, and online retail channels across Brazil, supported by a field sales team visiting 14,000+ sales points and engaging 86,000+ doctors. The company produces more than 50 million units annually.

Product overview

Myralis is a pharmaceutical company offering a portfolio of more than 30 health and wellness brands across supplements, medical devices, and medications. The product portfolio includes vitamin supplements (DPrev, MecoBe), a nasal wash device (Nasoar), a constipation treatment (PEG-Lax), pediatric supplements (Puravit), and a urinary health supplement (Urocran). The company distributes through pharmacies, drugstores, and online retailers across Brazil, and operates a loyalty program (Sua Saúde Myralis) and a medical education platform (Educa+ Myralis).

Differentiator

Problem solved

Functional benefit

Brands

• DPrev: Vitamin D (colecalciferol) dietary supplement that aids in bone and teeth formation, muscle functioning, and immune system functioning.
• Mecobe
• Nasoar
• Peg-Lax
• Puravit
• Urocran

Products and services

• DPrev Dietary supplement based on vitamin D (colecalciferol) that aids bone and teeth formation, muscle functioning, and immune system support. Indicated for maintaining adequate vitamin D levels in the blood. Marketed to adult consumers seeking vitamin D supplementation.
• MecoBe Sublingual mecobalamin (vitamin B12) supplement providing rapid absorption directly into the bloodstream without relying on gastrointestinal absorption. Indicated for B12 supplementation, including in people with gastric or intestinal absorption impairments.
• Nasoar High-volume nasal wash medical device that mechanically acts on the nasal mucosa, fluidifying and removing mucus to provide nasal decongestion and relief. Targeted at consumers with nasal congestion, allergies, or sinus discomfort.
• PEG-Lax Non-irritating osmotic laxative indicated for occasional constipation. Promotes stool softening and increased evacuation frequency by retaining water within the intestine. Targeted at adult consumers managing occasional digestive irregularity.
• Puravit Children's dietary supplement line developed to support healthy growth and development, providing important micronutrients for childhood health and wellness. Targeted at parents and caregivers of young children seeking nutritional supplementation.
• Urocran Food supplement containing Pacran, an exclusive cranberry (Vaccinium macrocarpon Aiton) extract with innovative extraction methods ensuring standardization, safety, and quality. Targeted at consumers seeking urinary tract health support.

Quantifiable outcome

• Over 50 million products produced annually

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Scale indicators5 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• EMS Pharma: One of Brazil's largest pharmaceutical manufacturers with a broad OTC and prescription portfolio sold through pharmacy chains nationwide. Highly comparable to Myralis given overlapping Brazil-focused distribution model, multi-brand OTC strategy, and similar target customers.
• Eurofarma: Major Brazilian pharmaceutical manufacturer with significant OTC and supplement offerings sold through drugstore chains. Comparable to Myralis in scale, geographic focus, and channel strategy within Brazil.
• Cimed: Brazilian pharmaceutical company with broad OTC and supplement brands (e.g., Viter C, Lavitan) sold heavily through pharmacy chains. Highly comparable to Myralis in portfolio approach, price-point positioning, and retail-channel dominance.
• Biolab Farmacêutica: Brazilian pharma company with a strong presence in prescription and OTC categories including supplements. Comparable to Myralis in scale, Brazilian focus, and reliance on doctor-channel and pharmacy distribution.
• Aché Laboratórios: Brazilian pharma company with a strong OTC, supplements, and consumer health portfolio distributed through retail pharmacies. Directly comparable to Myralis in product mix, brand portfolio breadth, and Brazilian pharmacy-channel GTM.

Broad incumbents

• Bayer Consumer Health: Global consumer health division with established OTC/vitamin brands (e.g., Redoxon, Elevit, Berocca) sold in Brazilian pharmacies. Comparable to Myralis in supplement category overlap but operates as a multinational incumbent with far greater scale and R&D.
• GSK Consumer Healthcare: Global consumer health company with OTC supplement brands (Centrum, Caltrate, Maltofer) sold through Brazilian pharmacies. Overlaps with Myralis in vitamin/mineral supplement categories but competes as a global incumbent with superior marketing budget and brand recognition.
• Hypera (formerly Hypermarcas): Brazil's largest consumer health/pharma company with marquee OTC brands across multiple categories. Larger and broader than Myralis but operates in the same Brazilian pharmacy channel with overlapping supplement and OTC segments.
• Sanofi Consumer Healthcare: Global pharma with a significant OTC and supplement portfolio (e.g., Enterogermina, Pharmaton) widely distributed through Brazilian pharmacies. Comparable in product categories but operates at much greater scale as a multinational incumbent.

Emerging players

• HERBAMED: Brazilian manufacturer of botanical and herbal supplements including cranberry-based products. Comparable to Myralis in the herbal/botanical supplement category (Urocran-style cranberry positioning) but smaller scale and narrower category focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/myralis_
• Facebookfacebook.com/myralispharma

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Myralis